PDS Biotechnology Reports Q2 2026 Results & Business Update

What Happened

• PDS Biotechnology Corporation announced on August 13, 2026 that it issued a press release providing a business update and its financial results for the quarter ended June 30, 2026. The company furnished the press release as Exhibit 99.1 to the Form 8-K.

Key Details

• Filing date: August 13, 2026; reporting period: quarter ended June 30, 2026.
• The press release containing the quarterly results and business update is attached to the 8-K as Exhibit 99.1.
• The company states the information is “furnished” under General Instruction B.2 of Form 8-K, not “filed,” meaning it is not subject to Section 18 liability and is not automatically incorporated by reference into other filings.
• The filing also includes the Inline XBRL cover page (Exhibit 104).

Why It Matters

• This 8-K provides investors with PDSB’s latest quarterly results and a business update (earnings, revenue and other operational details will be in the attached press release). Retail investors should review the press release to see the company’s reported revenue, earnings or other financial metrics and any commentary on near-term business plans.
• Note the legal designation (“furnished” vs. “filed”): while the information is publicly disclosed, it carries different legal implications and may not be incorporated into future SEC reports unless explicitly referenced.